Using Ki-67 protein staining, luciferase-based cAMP assay, flow cytometry and B16F10 melanoma cells, we found that activation of β2-ARs with isoproterenol increases cAMP levels in cancer cells, indicating that these receptors are functioning. Here, MKI67 is linked to melanoma.